These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved]. Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233 [TBL] [Abstract][Full Text] [Related]
4. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905 [TBL] [Abstract][Full Text] [Related]
5. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Chapman RH; Petrilla AA; Benner JS; Schwartz JS; Tang SS Drugs Aging; 2008; 25(10):885-92. PubMed ID: 18808213 [TBL] [Abstract][Full Text] [Related]
6. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence. Balu S; Simko RJ; Quimbo RM; Cziraky MJ Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511 [TBL] [Abstract][Full Text] [Related]
7. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications. Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308 [TBL] [Abstract][Full Text] [Related]
8. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653 [TBL] [Abstract][Full Text] [Related]
9. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367 [TBL] [Abstract][Full Text] [Related]
10. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791 [TBL] [Abstract][Full Text] [Related]
11. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review. Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396 [TBL] [Abstract][Full Text] [Related]
12. Increasing the detection and response to adherence problems with cardiovascular medication in primary care through computerized drug management systems: a randomized controlled trial. Tamblyn R; Reidel K; Huang A; Taylor L; Winslade N; Bartlett G; Grad R; Jacques A; Dawes M; Larochelle P; Pinsonneault A Med Decis Making; 2010; 30(2):176-88. PubMed ID: 19675319 [TBL] [Abstract][Full Text] [Related]
13. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457 [TBL] [Abstract][Full Text] [Related]
14. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997 [TBL] [Abstract][Full Text] [Related]
15. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004 [TBL] [Abstract][Full Text] [Related]
16. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C; Barner JC; Lawson KA; Johnsrud MT Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846 [TBL] [Abstract][Full Text] [Related]
17. Growth in use of lipid-lowering therapies: are we targeting the right patients? Dubois RW; Alexander CM; Wade S; Mosso A; Markson L; Lu JD; Nag S; Berger ML Am J Manag Care; 2002 Oct; 8(10):862-7. PubMed ID: 12395954 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Pittman DG; Tao Z; Chen W; Stettin GD Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390 [TBL] [Abstract][Full Text] [Related]
19. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]